Inhibiting Rac1-dependent signalling pathways concurrently reduced aSMC proliferation, airway hyperresponsiveness (AHR), and inflammation, presenting a novel approach to reverse airway remodelling and restore airway function in severe asthma patients. This evidence concerns the gene RAC1 and asthma.